Search Within

Tamanna Haque

Formats
  1. Meeting Abstract (9)
  2. Guidelines (1)
  3. Journal Article (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Adult Leukemia (9)
  2. Center for Hematologic Malignancies (9)
  3. Department of Medicine (9)
  4. Hematologic Malignancies, Division of (9)
  5. Department of Pathology and Laboratory Medicine (6)
  6. Weinberg Fellows (6)

More Groups

People
  1. Mark Geyer (5)
  2. Aaron Goldberg (4)
  3. Eytan Stein (4)
  4. Lindsey Roeker (4)
  5. Raajit Rampal (4)
  6. Andriy Derkach (3)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (5)
Publications
  1. Blood (7)
  2. British Journal of Haematology (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. Haematologica (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of the National Comprehensive Cancer Network (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Ferrata Storti Foundation (1)
  5. Harborside Press (1)
  6. John Wiley & Sons (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myelodysplastic syndromes, version 2.2025: Featured updates to the NCCN guidelines
    Guidelines

    Greenberg, P. L.; Stone, R. M.; Abaza, Y.; Al-Kali, A.; Anand, S.; Ball, B.; Bennett, J. M.; Borate, U.; Brunner, A. M.; Chai-Ho, W.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis
    Review

    Haque, T.; Shastri, A.; Desai, P.; Xie, Z.; Hammond, D.; King, Z.; Kishtagari, A.; Madanat, Y. F.; Abaza, Y.; Silver, A. J.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Journal Article

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G. K.; Borge, P. D.; Geyer, M.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Meeting Abstract

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G.; Borge, P.; Geyer, M. B.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Nuvisertib (TP-3654), an investigational selective PIM1 kinase inhibitor, showed durable clinical response and sustained hematological improvement in relapsed/refractory myelofibrosis patients
    Meeting Abstract

    El Chaer, F.; Rein, L. A. M.; Yuda, J.; Shimoda, K.; Takami, A.; Ichii, M.; McCloskey, J.; Scandura, J. M.; Iurlo, A.; Bose, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Preliminary safety and biomarker results of the NLRP3 inflammasome inhibitor DFV890 in adult patients with myeloid diseases: A phase 1b study
    Meeting Abstract

    Garcia-Manero, G.; Abaza, Y.; Greenberg, P. L.; Haque, T.; Kennedy, K. V.; Della Porta, M. G.; Ooi, M. G.; Stahl, M.; Xie, Z.; Mangaonkar, A. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Safety and preliminary efficacy of DFV890 in adult patients with myeloid diseases: A phase 1b study
    Meeting Abstract

    Garcia-Manero, G.; Ooi, M.; Lao, Z. T.; Gill, H.; Abaza, Y.; Stahl, M.; Haque, T.; DeZern, A. E.; Greenberg, P. L.; Pelletier, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 1/2 study of TP-3654, a selective PIM1 kinase inhibitor: Preliminary data showed clinical activity and cytokine reductions in relapsed/refractory myelofibrosis patients
    Meeting Abstract

    Rein, L. A. M.; El Chaer, F.; Yuda, J.; Shimoda, K.; McCloskey, J.; Takami, A.; Haque, T.; Ichii, M.; Shirane, S.; Fukaya, M.; more...
    Blood (2023)

    Fulltext@MSK | Save